跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NARCAN NEONATAL naloxone hydrochloride 40microgram/2mL injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
NARCAN NEONATAL naloxone hydrochloride 40microgram/2mL injection ampoule
Approved
STANDARD
NARCAN NEONATAL naloxone hydrochloride 40microgram/2mL injection ampoule
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8b7ea1eb4c6b169a
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
8b7ea1eb4c6b169a
Product Name
NARCAN NEONATAL naloxone hydrochloride 40microgram/2mL injection ampoule
Artg Id
57305
Artg Name
NARCAN NEONATAL naloxone hydrochloride 40microgram/2mL injection ampoule
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
1997-10-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8b7ea1eb4c6b169a
Type
Standard
Back to TGA Approvals
